Src promotes tumor cell invasion by hijacking the translation machineries
Cell Reports · 2026-03 · 45 (3) · 116989
DOI: 10.1016/j.celrep.2026.116989 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2026-03. Verfasst von Benjamin Bonnard und 13 weiteren Autor:innen. Beteiligte Einrichtung: Bordeaux Institute of Oncology, BRIC U1312, INSERM, Université de Bordeaux, 33076 Bordeaux, France. Electronic address: benjamin.bonnard@inserm.fr. Hauptthemen laut MEDLINE: Protein Biosynthesis, src-Family Kinases, Liver Neoplasms, Carcinoma, Hepatocellular. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National League Against Cancer, Agence Nationale de la Recherche, French National Cancer Institute.
Abstract (Originalsprache)
The Src oncogene controls cancer cell invasiveness by promoting invadosome formation and extracellular matrix (ECM) degradation. Invadosomes are translational hotspots enriched in the eukaryotic translation initiation factor 3 (eIF3) complex that is mandatory for their maintenance. Here, we determined that Src regulates mRNA translation and controls the expression of eIF3 subunits, including eIF3h, eIF3e, and eIF3d. These subunits are crucial for invadosome formation and ECM degradation. Src also modulates both canonical eIF4E-dependent translation via the activation of the phosphoinositide-3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) pathway and the non-canonical translation mechanism through eIF3d overexpression, both of which are necessary for invadosome function. Moreover, overexpression of Src and eIF3h/e/d correlates with poor prognosis in patients with hepatocellular carcinoma (HCC), promoting ECM degradation and tumor invasiveness of HCC cells. This study identifies Src as a major regulator of translation initiation, modulating invadosome formation, ECM degradation, and tumor cell invasion.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Bordeaux Institute of Oncology, BRIC U1312, INSERM, Université de Bordeaux, 33076 Bordeaux, France. Electronic address: benjamin.bonnard@inserm.fr.
- Bordeaux Institute of Oncology, BRIC U1312, INSERM, Université de Bordeaux, 33076 Bordeaux, France.
- Bordeaux Institute of Oncology, BRIC U1312, INSERM, Université de Bordeaux, 33076 Bordeaux, France; Oncoprot Platform, TBM-Core US 005, 33076 Bordeaux, France.
- Oncoprot Platform, TBM-Core US 005, 33076 Bordeaux, France.
- Centre de Recherche en Cancérologie de Toulouse (CRCT), INSERM U1037, Université Toulouse III Paul Sabatier, ERL5294 CNRS, 31037 Toulouse, France.
- Montpellier Cell Biology Research Center, CRBM, Université de Montpellier, CNRS, 34293 Montpellier, France.
Förderung
- National League Against Cancer
- Agence Nationale de la Recherche
- French National Cancer Institute
Zitieren
APA
Bonnard, B., Chatefau, A., Dourthe, C., Di Tommaso, S., Dupuy, J. W., Mahouche, I., Solorzano, J., Le Bras, M., Raymond, A. A., Moreau, V., Jabouille, A., Blangy, A., Martineau, Y., & Saltel, F. (2026). Src promotes tumor cell invasion by hijacking the translation machineries. Cell Reports, 45(3), 116989. https://doi.org/10.1016/j.celrep.2026.116989
Vancouver
Bonnard B, Chatefau A, Dourthe C, Di Tommaso S, Dupuy JW, Mahouche I, et al. Src promotes tumor cell invasion by hijacking the translation machineries. Cell Reports. 2026;45(3):116989. doi:10.1016/j.celrep.2026.116989
BibTeX
@article{Bonnard2026,
author = {Bonnard, Benjamin and Chatefau, Anouk and Dourthe, Cyril and Di Tommaso, Sylvaine and Dupuy, Jean-William and Mahouche, Isabelle and Solorzano, Jacobo and Le Bras, Morgane and Raymond, Anne-Aurélie and Moreau, Violaine and Jabouille, Arnaud and Blangy, Anne and Martineau, Yvan and Saltel, Frédéric},
title = {Src promotes tumor cell invasion by hijacking the translation machineries},
journal = {Cell Reports},
year = {2026},
volume = {45},
number = {3},
pages = {116989},
doi = {10.1016/j.celrep.2026.116989}
}
EUVIMED